BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 12473340)

  • 1. A revised picture of the E2F transcriptional network and RB function.
    Stevaux O; Dyson NJ
    Curr Opin Cell Biol; 2002 Dec; 14(6):684-91. PubMed ID: 12473340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles for E2F: beyond the G1/S transition and DNA replication.
    Cam H; Dynlacht BD
    Cancer Cell; 2003 Apr; 3(4):311-6. PubMed ID: 12726857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aberrant regulation of survivin by the RB/E2F family of proteins.
    Jiang Y; Saavedra HI; Holloway MP; Leone G; Altura RA
    J Biol Chem; 2004 Sep; 279(39):40511-20. PubMed ID: 15271987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F; Lovec H; Möröy T; Lipp M
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unbiased analysis of RB-mediated transcriptional repression identifies novel targets and distinctions from E2F action.
    Markey MP; Angus SP; Strobeck MW; Williams SL; Gunawardena RW; Aronow BJ; Knudsen ES
    Cancer Res; 2002 Nov; 62(22):6587-97. PubMed ID: 12438254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E2F transcriptional network: old acquaintances with new faces.
    Dimova DK; Dyson NJ
    Oncogene; 2005 Apr; 24(17):2810-26. PubMed ID: 15838517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional repression and activation in the same cell type of the human c-MYC promoter by the retinoblastoma gene protein: antagonisation of both effects by SV40 T antigen.
    Batsché E; Lipp M; Cremisi C
    Oncogene; 1994 Aug; 9(8):2235-43. PubMed ID: 8036009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle-regulated expression of mammalian CDC6 is dependent on E2F.
    Hateboer G; Wobst A; Petersen BO; Le Cam L; Vigo E; Sardet C; Helin K
    Mol Cell Biol; 1998 Nov; 18(11):6679-97. PubMed ID: 9774682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function.
    Wang S; Nath N; Adlam M; Chellappan S
    Oncogene; 1999 Jun; 18(23):3501-10. PubMed ID: 10376528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Active transcriptional repression by the Rb-E2F complex mediates G1 arrest triggered by p16INK4a, TGFbeta, and contact inhibition.
    Zhang HS; Postigo AA; Dean DC
    Cell; 1999 Apr; 97(1):53-61. PubMed ID: 10199402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytosine methylation transforms an E2F site in the retinoblastoma gene promoter into a binding site for the general repressor methylcytosine-binding protein 2 (MeCP2).
    Di Fiore B; Palena A; Felsani A; Palitti F; Caruso M; Lavia P
    Nucleic Acids Res; 1999 Jul; 27(14):2852-9. PubMed ID: 10390525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The E2F transcription factor activates a replication-dependent human H2A gene in early S phase of the cell cycle.
    Oswald F; Dobner T; Lipp M
    Mol Cell Biol; 1996 May; 16(5):1889-95. PubMed ID: 8628255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Rb/chromatin connection and epigenetic control: opinion.
    Ferreira R; Naguibneva I; Pritchard LL; Ait-Si-Ali S; Harel-Bellan A
    Oncogene; 2001 May; 20(24):3128-33. PubMed ID: 11420729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Rb/E2F pathway and cancer.
    Nevins JR
    Hum Mol Genet; 2001 Apr; 10(7):699-703. PubMed ID: 11257102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. pRb and E2f-1 in mouse development and tumorigenesis.
    Macleod K
    Curr Opin Genet Dev; 1999 Feb; 9(1):31-9. PubMed ID: 10072353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent transrepression domain in the retinoblastoma protein induces a cell cycle arrest when bound to E2F sites.
    Sellers WR; Rodgers JW; Kaelin WG
    Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11544-8. PubMed ID: 8524800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rb/E2F: a two-edged sword in the melanocytic system.
    Halaban R
    Cancer Metastasis Rev; 2005 Jun; 24(2):339-56. PubMed ID: 15986142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
    Nakajima Y
    Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.